Search Results 191-200 of 16441 for Proto-oncogene
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...
Learn about these tumors that form from reproductive cells. Explore treatment options, including surgery, chemotherapy and radiation therapy.
The purpose of this study is to evaluate the effectiveness of ONC201 administered following radiotherapy in participants with H3 K27M-mutant diffuse glioma. A ...
At Mayo Clinic, you have access to the latest advances and proven innovations for diagnosing and treating cancer. Not all services are provided at all ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
In a prospective, multisite study, 15.2% of patients with pancreatic cancer were found to have a genetic predisposition to this deadly disease.
[ALK]/ c-ros oncogene 1 [ROS1]) per National Comprehensive Cancer Network (NCCN) guidelines, participant has also been previously treated with or is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.